Amylase Quantitative Testing Drug - Vietnam Registration 220002133/PCBB-BYT
Access comprehensive regulatory information for Amylase Quantitative Testing Drug in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loแบกi B medical device is registered under number 220002133/PCBB-BYT and manufactured by Abbott Ireland Diagnostics Division.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Abbott Ireland Diagnostics Division, and 2 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Technical Details
Amylase2 testing is used to quantify amylase in human serum, plasma, or urine on the ARCHITECT c Systems. Amylase2 testing is primarily used to support the diagnosis and treatment of pancreatitis (inflammation of the pancreas).
Dates and Status
Apr 27, 2022